Advertisement

Surgical Endoscopy

, Volume 32, Issue 10, pp 4063–4067 | Cite as

SAGES review of endoscopic and minimally invasive bariatric interventions: a review of endoscopic and non-surgical bariatric interventions

  • Marina KurianEmail author
  • Matthew Kroh
  • Bipan Chand
  • Dean Mikami
  • Kevin Reavis
  • Leena Khaitan
Review Article

Abstract

Background

With obesity continuing as a global epidemic and therapeutic technologies advancing, several novel endoscopic and minimally invasive interventions will likely become available as treatment options. With improved technologies and different treatment strategies, as well as different patient populations being targeted, there will be greater application in the treatment armamentarium of specialists dedicated to treating obesity. We sought to review the existing technology and provide a review.

Methods

Literature review was carried out for endoscopic and minimally invasive devices. Some of these products are not FDA approved, so limited data are available in their review.

Results

A summary of the device and data currently available on weight loss and safety profile is provided. Several products are in clinical trials or will be soon. Some of the technology has limited data and companies will be submitting their results for FDA evaluation.

Conclusions

The obesity epidemic and associated weight-related diseases represent a tremendous burden to health care practitioners. As such, a multi-modal and progressive approach, with data and outcomes examined, is likely the best and most comprehensive method to care for these patients. SAGES endorses the benefits of minimally invasive and endoscopic approaches in the treatment of obesity and its related co-morbidities.

Keywords

Endoscopic obesity treatment Bariatric endoscopic therapy 

Notes

Acknowledgements

This article came from work done within the SAGES and ASMBS Endoscopic Bariatric Task Forces.

Compliance with ethical standards

Disclosures

Marina Kurian has been faculty for Apollo Endosurgery. Kevin Reavis has been faculty for Apollo Endosurgery, and is a PI for EndoBarrier multicenter trial. Matthew Kroh, Bipan Chand, Dean Mikami, and Leena Khaitan have no conflicts of interest or financial ties to disclose.

References

  1. 1.
    Mion F, Ibrahim M, Marjoux S, Ponchon T, Dugardeyn S, Roman S, Deviere J (2013) Swallowable Obalon® gastric balloons as an aid for weight loss: a pilot feasibility study. Obes Surg 23(5):730–733.  https://doi.org/10.1007/s11695-013-0927-x CrossRefPubMedGoogle Scholar
  2. 2.
    Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen LE, Gostout C, Lopez-Nava G, Shikora S, Brooks J (2011) Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg 21(10):1499–1507CrossRefGoogle Scholar
  3. 3.
    Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S (2013) Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology 145(6):1245–1252, e1–5CrossRefGoogle Scholar
  4. 4.
    Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ (2017) Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol 112(3):447–457.  https://doi.org/10.1038/ajg.2016.500.CrossRefGoogle Scholar
  5. 5.
    Marinos G, Eliades C, Greenway F, Muthuswamy R (2014) Weight loss and improved quality of life with a novel, non-surgical endoscopic treatment for obesity: clinical results from a 3 and 6 month study. Surg Obes Relat Dis Sep-Oct 10(5):929–934CrossRefGoogle Scholar
  6. 6.
    Rohde U, Hedbäck N, Gluud LL, Vilsbøll T, Knop FK (2016) Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 18(3):300–305CrossRefGoogle Scholar
  7. 7.
    Sandler BJ, Rumbaut R, Swain CP, Torres G, Morales L, Gonzales L, Schultz S, Talamini MA, Jacobsen GR, Horgan S (2015) One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc 29(11):3298–3303CrossRefGoogle Scholar
  8. 8.
    Machytka E, Buzga M, Zonca P, Lautz D, Ryou M, Simonson D, Thompson C (2017) Partial Jejunal Diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes. Gastroint Endosc 86(5):904–912CrossRefGoogle Scholar
  9. 9.
    Sharaiha RZ, Kedia P, Kumta N, DeFilippis EM, Gaidhane M, Shukla A, Aronne LJ, Kahaleh M (2015) Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy 47(2):164–166PubMedGoogle Scholar
  10. 10.
    Thompson C. https://clinicaltrials.gov/ct2/show/NCT01662024. Last update 30 March 2017. Last accessed 12 Jan 2018
  11. 11.
    Huberty V. https://clinicaltrials.gov/ct2/show/NCT03255005. Last update 25 Sept 2007. Last accessed 12 Jan 2018
  12. 12.
    Novikov AA, Afaneh C, Saumoy M, Parra V, Shukla A, Dakin GF, Pomp A, Dawod E, Shah S, Aronne LJ, Sharaiha RZ (2017) Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare? J Gastrointest Surg.  https://doi.org/10.1007/s11605-017-3615-7 CrossRefPubMedGoogle Scholar
  13. 13.
    Movitz BR, Lutfi RE (2017) Endoscopic sleeve gastroplasty: are we burning bridges? Surg Obes Relat Dis 13(12):2056–2058.  https://doi.org/10.1016/j.soard.2017.09.520 CrossRefPubMedGoogle Scholar
  14. 14.
    Salsamendi J, Pereira K, Kang K, Fan J (2015). Minimally invasive percutaneous endovascular therapies in the management of complications of non-alcoholic fatty liver disease (NAFLD): a case report. J Radiol Case Rep 9(9):36–43PubMedPubMedCentralGoogle Scholar
  15. 15.
    Bai ZB, Qin YL, Deng G, Zhao GF, Zhong BY, Teng GJ (2017) Bariatric embolization of the left gastric arteries for the treatment of obesity: 9-month data in 5 patients. Obes Surg.  https://doi.org/10.1007/s11695-017-2979-9 CrossRefGoogle Scholar
  16. 16.
    Harat M, Rudaś M, Zieliński P, Birska J, Sokal P (2016) Nucleus accumbens stimulation in pathological obesity. Neurol Neurochir Pol 50(3):207–210CrossRefGoogle Scholar
  17. 17.
  18. 18.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Marina Kurian
    • 1
    Email author
  • Matthew Kroh
    • 2
  • Bipan Chand
    • 3
  • Dean Mikami
    • 4
  • Kevin Reavis
    • 5
  • Leena Khaitan
    • 6
  1. 1.Department of SurgeryNYU Langone Medical CenterNew YorkUSA
  2. 2.Department of SurgeryCleveland Clinic Abu DhabiAbu DhabiUnited Arab Emirates
  3. 3.Department of SurgeryLoyola University, Stritch School of MedicineMaywoodUSA
  4. 4.Department of SurgeryUniversity of HawaiiHonoluluUSA
  5. 5.The Oregon Clinic; Legacy Weight & Diabetes InstitutePortlandUSA
  6. 6.Department of SurgeryUniversity HospitalsClevelandUSA

Personalised recommendations